Stephen J. Hill
Birmingham, ENG NG72UH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Discovery of uracil-based antagonists and fluorescent ligands of the P2Y2 receptor.
Journal: European journal of medicinal chemistry
Published: July 09, 2026
Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Two-Step Ligand-Directed Covalent Fluorescent Labeling of the Adenosine A1-Receptor That Maintains Its Orthosteric Binding Site's Availability to Bind Ligands.
Journal: Journal of medicinal chemistry
Published: January 08, 2026
CXCR4-EGFR heteromers show ligand-dependent changes in conformation and signaling.
Journal: Cell chemical biology
Published: November 14, 2025
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.
Journal: The Journal of experimental medicine
Published: October 27, 2025
Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.
Journal: Oncogene
Published: August 06, 2025
Quantitative analysis of human umbilical vein endothelial cell morphology and tubulogenesis.
Journal: Journal of microscopy
Published: December 10, 2024
Acute vascular and cardiac effects of lenvatinib in mice.
Journal: Cardio-oncology (London, England)
Published: September 19, 2024
Ligand-Directed Labeling of the Adenosine A1 Receptor in Living Cells.
Journal: Journal of medicinal chemistry
Published: July 12, 2024
Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y2 Receptor.
Journal: ACS medicinal chemistry letters
Published: May 07, 2024
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans.
Journal: Science signaling
Published: March 19, 2024
Last Updated: 09/26/2026